(NASDAQ: TOI) Oncology Institute's forecast annual revenue growth rate of 25.42% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.01%.
Oncology Institute's revenue in 2026 is $545,764,000.On average, 6 Wall Street analysts forecast TOI's revenue for 2026 to be $65,834,762,063, with the lowest TOI revenue forecast at $62,768,285,508, and the highest TOI revenue forecast at $70,390,984,320. On average, 5 Wall Street analysts forecast TOI's revenue for 2027 to be $83,359,770,559, with the lowest TOI revenue forecast at $76,138,003,309, and the highest TOI revenue forecast at $91,355,405,711.
In 2028, TOI is forecast to generate $109,981,226,300 in revenue, with the lowest revenue forecast at $106,681,789,511 and the highest revenue forecast at $114,280,492,419.